These pro-apoptotic and anti-proliferative mechanisms may be attributable to a combination of direct inhibition of cancer cell growth by interfering with the EGFR autocrine pathway and the secondary anti-angiogenic effects of VEGFR-2 blockade in endothelial cells8. The gene discussed is EGFR; the disease is cancer.